Selgantolimod

N/A

Report date: 2026/04/12 20:00:13
NME

Base Information

Drug NameSelgantolimod
Drug Alias NameGS-9688
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 agonists
TargetsToll like receptor 8
Therapy Area/IndicationsHepatitis B, ChronicHepatitis BHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[17] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis BHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A